Maxcyte (DI) (MXCT)

122.00p
   
  • Change Today:
    -2.00p
  • 52 Week High: 242.00p
  • 52 Week Low: 115.00p
  • Currency: UK Pounds
  • Shares Issued: 51.36m
  • Volume: 15,000
  • Market Cap: £62.66m

Regulatory News

Grant of Options 05-Mar-2019 07:00 RNS
Clinical & Commercial Agreement with Kite 01-Mar-2019 07:00 RNS
Result of Special Meeting and Issue of Equity 26-Feb-2019 17:32 RNS
Results of Placing 05-Feb-2019 16:32 RNS
Proposed Placing to raise a minimum of £10 ... 05-Feb-2019 07:00 RNS
Trading Update 15-Jan-2019 07:00 RNS
Change of Auditor 19-Dec-2018 07:00 RNS
Director Dealings 17-Dec-2018 18:06 RNS
Consolidation of Trading Lines 21-Nov-2018 07:00 RNS
Block Admission Six Monthly Return/TVR 20-Nov-2018 07:00 RNS
Webinar: non-viral cell engineering 16-Nov-2018 07:00 RNS
Clinical and Commercial License Agreement 14-Nov-2018 07:00 RNS
MaxCyte Announces Research Agreement with Kite 12-Nov-2018 07:00 RNS
Expansion of CRISPR Commercial License Agreement 09-Nov-2018 07:00 RNS
Result of AGM 31-Oct-2018 16:25 RNS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Maxcyte (DI) Market Data

Currency UK Pounds
Share Price 122.00p
Change Today -2.00p
% Change -1.61 %
52 Week High 242.00p
52 Week Low 115.00p
Volume 15,000
Shares Issued 51.36m
Market Cap £62.66m

Maxcyte (DI) Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend Not Available
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Maxcyte (DI) Dividends

No dividends found

Trades for 19-Sep-2019

Time Volume / Share Price
12:32 15,000 @ 121.50p

Maxcyte (DI) Key Personnel

CEO Doug Doerfler
CFO Ron Holtz

Top of Page